Massmutual Trust CO Fsb Alnylam Pharmaceuticals, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.28 Billion
- Q2 2024
A detailed history of Massmutual Trust CO Fsb transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 39 shares of ALNY stock, worth $9,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 38
2.63%
Holding current value
$9,275
Previous $5,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ALNY
# of Institutions
591Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.04 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$2.85 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.15 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.71 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.58 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...